Loss of hepatitis A virus (HAV) antibodies after peripheral stem cell transplantation (PSCT).
The majority of patients with hepatitis A have a benign course, but some may develop fulminant hepatitis and hematological complications. Peripheral stem cell transplantation (PSCT) is associated with loss of immunity. There are no data regarding loss of HAV antibodies (anti-HAV) after PSCT. We retrospectively evaluated the persistence of anti-HAV in a nonvaccinated population that underwent PSCT. Serum detection of anti-HAV was determined before and after PSCT using a qualitative commercially available enzyme immunoassay. From January 1997 to March 2001, 136 (68%) of 201 patients tested (+) for anti-HAV prior to PSCT. Subsequent investigation of anti-HAV was possible in 36 of these patients at a median of 12 months after PSCT. The median age of patients was 47 years old; they had diagnoses of hematological malignancies (33) and solid tumors (three), and underwent autologous (31) and allogenic (five) PSCT. A total of 31 (86%) of 36 patients remained anti-HAV (+) and five (14%) became (-) after PSCT. The variables age, sex, diagnosis, type of PSCT, time of testing, and number of CD34 cells infused were not predictors of loss of anti-HAV. In conclusion, 14% of 36 nonvaccinated anti-HAV (+) patients lost their antibodies at a median of 12 months after PSCT.
Dignani
M C
MC
FUNDALEU (Foundation for the Fight against Leukemia), Buenos Aires, Argentina.
Miceli
M H
MH
Rosa
C M
CM
Gatica
J
J
Martínez-Rolón
J
J
Pizzolato
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000917:Antibody Formation; D005260:Female; D019337:Hematologic Neoplasms / Q000628:therapy; D035922:Hepatitis A Antibodies / Q000097:blood*; D006801:Humans; D007114:Immunization; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D012189:Retrospective Studies; D016036:Seroepidemiologic Studies; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D035922:Hepatitis A Antibodies